Works matching AU PERKOVIC, VLADO

Results: 185

The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials.

Published in:

Journal of the American Geriatrics Society, 2025, v. 73, n. 6, p. 1787, doi. 10.1111/jgs.19444

By:

Nguyen, Tu N.;
Yu, Jie;
Perkovic, Vlado;
Jardine, Meg;
Mahaffey, Kenneth W.;
Chow, Clara K.;
Arnott, Clare;
Lindley, Richard I.

Publication type:

Article

The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system.

Published in:

Peritoneal Dialysis International, 2025, v. 45, n. 1, p. 52, doi. 10.1177/08968608231209850

By:

Talbot, Benjamin;
Davies, Simon;
Burman, Jenny;
Ritchie, Angus;
Snelling, Paul;
Lynch, Sue;
Park, Youn;
Jones, Brian;
Garvey, Vincent;
Jaure, Allison;
Jardine, Meg;
Perkovic, Vlado;
Gallagher, Martin;
Brandwood, Arthur;
Kaur, Navneet;
Knight, John

Publication type:

Article

Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1972, doi. 10.1111/dom.16190

By:

Siriwardana, Amanda;
Buizen, Luke;
Jun, Min;
Kotwal, Sradha;
Arnott, Clare;
Jardine, Meg J.;
Levin, Adeera;
Heerspink, Hiddo J. L.;
Charytan, David M.;
Pollock, Carol;
Perkovic, Vlado;
Neuen, Brendon L.

Publication type:

Article

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685

By:

Cardoza, Kathryn;
Kang, Amy;
Smyth, Brendan;
Yi, Tae Won;
Pollock, Carol;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Wheeler, David C.;
Zhang, Hong;
Cannon, Christopher P.;
Perkovic, Vlado;
Arnott, Clare;
Levin, Adeera;
Mahaffey, Kenneth W.

Publication type:

Article

Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678

By:

Tangri, Navdeep;
Ferguson, Thomas W.;
Bamforth, Ryan J.;
Leon, Silvia J.;
Arnott, Clare;
Mahaffey, Kenneth W.;
Kotwal, Sradha;
Heerspink, Hiddo J. L.;
Perkovic, Vlado;
Fletcher, Robert A.;
Neuen, Brendon L.

Publication type:

Article

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340

By:

Sharma, Abhinav;
Marques, Pedro;
Neuen, Brendon L.;
Fletcher, Robert A.;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Arnott, Clare;
Levin, Adeera;
Verma, Subodh;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3724, doi. 10.1111/dom.15267

By:

Yu, Jie;
Sweeting, Arianne N.;
Gianacas, Chris;
Houston, Lauren;
Lee, Vivian;
Fletcher, Robert A.;
Perkovic, Vlado;
Li, Qiang;
Neuen, Brendon L.;
Berwanger, Otavio;
Heerspink, Hiddo J. L.;
de Zeeuw, Dick;
Arnott, Clare

Publication type:

Article

Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232

By:

Heerspink, Hiddo J. L.;
Vart, Priya;
Jongs, Niels;
Neuen, Brendon L.;
Bakris, George;
Claggett, Brian;
Vaduganathan, Muthiah;
McCausland, Finnian;
Docherty, Kieran F.;
Jhund, Pardeep S.;
Solomon, Scott D.;
Perkovic, Vlado;
McMurray, John J. V.

Publication type:

Article

Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2331, doi. 10.1111/dom.15112

By:

Sridhar, Vikas S.;
Neuen, Brendon L.;
Fletcher, Robert A.;
Slee, April;
Ang, Fernando G.;
Rapattoni, Wally;
Arnott, Clare;
Cherney, David Z.;
Perkovic, Vlado;
Wheeler, David C.;
Levin, Adeera

Publication type:

Article

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091

By:

Kang, Amy;
Smyth, Brendan;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Di Tanna, Gian Luca;
Zhang, Hong;
Arnott, Clare;
Hockham, Carinna;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Greene, Tom;
Levin, Adeera;
Pollock, Carol;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Jardine, Meg J.

Publication type:

Article

Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065

By:

Yi, Tae Won;
Wong, Michelle M.Y.;
Neuen, Brendon L.;
Arnott, Clare;
Poirier, Paul;
Seufert, Jochen;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Levin, Adeera

Publication type:

Article

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978

By:

Koshino, Akihiko;
Oshima, Megumi;
Arnott, Clare;
Fletcher, Robert A.;
Bakris, George L.;
Jardine, Meg;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Pollock, Carol;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.

Publication type:

Article

Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832

By:

Nunes, Julio C.;
Yu, Jie;
Arnott, Clare;
Jardine, Meg J.;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772

By:

Li, Chao;
Yu, Jie;
Hockham, Carinna;
Perkovic, Vlado;
Neuen, Brendon L.;
Badve, Sunil V.;
Houston, Lauren;
Lee, Vivian Y. J.;
Barraclough, Jennifer Y.;
Fletcher, Robert A.;
Mahaffey, Kenneth W.;
Heerspink, Hiddo J. L.;
Cannon, Christopher P.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671

By:

Barraclough, Jennifer Y.;
Yu, Jie;
Figtree, Gemma A.;
Perkovic, Vlado;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.;
Cannon, Christopher P.;
Mahaffey, Kenneth W.;
Schutte, Aletta E.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 983, doi. 10.1111/dom.14660

By:

Waijer, Simke W.;
Provenzano, Michele;
Mulder, Skander;
Rossing, Peter;
Persson, Frederik;
Perkovic, Vlado;
Heerspink, Hiddo J. L.

Publication type:

Article

Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525

By:

Feng, Kent Y.;
Li, JingWei;
Ianus, Juliana;
de Zeeuw, Dick;
Fulcher, Greg R.;
Pfeifer, Michael;
Matthews, David R.;
Jardine, Meg J.;
Perkovic, Vlado;
Neal, Bruce;
Mahaffey, Kenneth W.

Publication type:

Article

Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2058, doi. 10.1111/dom.14443

By:

Mann, Johannes F. E.;
Buse, John B.;
Idorn, Thomas;
Leiter, Lawrence A.;
Pratley, Richard E.;
Rasmussen, Søren;
Vilsbøll, Tina;
Wolthers, Benjamin;
Perkovic, Vlado

Publication type:

Article

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386

By:

Arnott, Clare;
Li, Jing‐Wei;
Cannon, Christopher P.;
Zeeuw, Dick;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Charytan, David M.;
Agarwal, Anubha;
Huffman, Mark D.;
Figtree, Gemma A.;
Bakris, George;
Chang, Tara I‐Hsin;
Feng, Kent;
Rosenthal, Norman;
Zinman, Bernard;
Jardine, Meg J.;
Perkovic, Vlado;
Neal, Bruce;
Mahaffey, Kenneth W.

Publication type:

Article

Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1420, doi. 10.1111/dom.14351

By:

Jun, Min;
Harris, Katie;
Heerspink, Hiddo J. L.;
Badve, Sunil V.;
Jardine, Meg J.;
Harrap, Stephen;
Hamet, Pavel;
Marre, Michel;
Poulter, Neil;
Kotwal, Sradha;
Gallagher, Martin;
Perkovic, Vlado;
Chalmers, John;
Woodward, Mark

Publication type:

Article

The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 763, doi. 10.1111/dom.14281

By:

O'Hara, Daniel V.;
Parkhill, Thomas R.;
Badve, Sunil V.;
Jun, Min;
Jardine, Meg J.;
Perkovic, Vlado

Publication type:

Article

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252

By:

Koomen, Jeroen V.;
Stevens, Jasper;
Bakris, George;
Correa‐Rotter, Ricardo;
Hou, Fan Fan;
Kitzman, Dalane W.;
Kohan, Donald;
Makino, Hirofumi;
McMurray, John J. V.;
Parving, Hans‐Henrik;
Perkovic, Vlado;
Tobe, Sheldon W.;
Zeeuw, Dick;
Heerspink, Hiddo J. L.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226

By:

Neuen, Brendon L.;
Arnott, Clare;
Perkovic, Vlado;
Figtree, Gemma;
Zeeuw, Dick;
Fulcher, Greg;
Jun, Min;
Jardine, Meg J.;
Zoungas, Sophia;
Pollock, Carol;
Mahaffey, Kenneth W.;
Neal, Bruce;
Heerspink, Hiddo J. L.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197

By:

Li, Chao;
Zhou, Zien;
Neuen, Brendon L.;
Yu, Jie;
Huang, Yuli;
Young, Tamara;
Li, Jingwei;
Li, Lin;
Perkovic, Vlado;
Jardine, Meg J.;
Keay, Lisa;
Markoulli, Maria;
Rosenthal, Norm;
Capuano, George;
Yavin, Yshai;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143

By:

Matthews, David R.;
Wysham, Carol;
Davies, Melanie;
Slee, April;
Alba, Maria;
Lee, Mary;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Neal, Bruce

Publication type:

Article

The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091

By:

Arnott, Clare;
Huang, Yuli;
Neuen, Brendon L;
Di Tanna, Gian Luca;
Cannon, Christopher P.;
Oh, Richard;
Edwards, Robert;
Kavalam, Mary;
Rosenthal, Norman;
Perkovic, Vlado;
Jardine, Meg J;
Mahaffey, Kenneth;
Neal, Bruce

Publication type:

Article

Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 530, doi. 10.1111/dom.13920

By:

Ohkuma, Toshiaki;
Van Gaal, Luc;
Shaw, Wayne;
Mahaffey, Kenneth W.;
Zeeuw, Dick;
Matthews, David R.;
Perkovic, Vlado;
Neal, Bruce

Publication type:

Article

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1237, doi. 10.1111/dom.13648

By:

Toyama, Tadashi;
Neuen, Brendon L.;
Jun, Min;
Ohkuma, Toshiaki;
Neal, Bruce;
Jardine, Meg J.;
Heerspink, Hiddo L.;
Wong, Muh Geot;
Ninomiya, Toshiharu;
Wada, Takashi;
Perkovic, Vlado

Publication type:

Article

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, p. 14, doi. 10.1111/dom.13417

By:

Heerspink, Hiddo J. L.;
List, James;
Perkovic, Vlado

Publication type:

Article

Baseline characteristics and enrichment results from the SONAR trial.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1829, doi. 10.1111/dom.13315

By:

Heerspink, Hiddo J. L.;
Andress, Dennis L.;
Bakris, George;
Brennan, John J.;
Correa‐Rotter, Ricardo;
Hou, Fan Fan;
Kitzman, Dalane W.;
Kohan, Donald;
Makino, Hirofumi;
McMurray, John;
Perkovic, Vlado;
Tobe, Sheldon;
Wigderson, Melissa;
Yi, Tingting;
Parving, Hans‐Henrik;
de Zeeuw, Dick

Publication type:

Article

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1369, doi. 10.1111/dom.13245

By:

Heerspink, Hiddo J. L.;
de Zeeuw, Dick;
Perkovic, Vlado;
Tobe, Sheldon;
Parving, Hans‐Henrik;
Andress, Dennis L.;
Brennan, John J.;
Dey, Jyotirmoy;
Wigderson, Melissa;
Bakris, George;
Correa‐Rotter, Ricardo;
Hou, Fan Fan;
Kitzman, Dalane W.;
Kohan, Donald;
Makino, Hirofumi;
McMurray, John

Publication type:

Article

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA- T2D trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1610, doi. 10.1111/dom.13041

By:

Groop, Per‐Henrik;
Cooper, Mark E.;
Perkovic, Vlado;
Hocher, Berthold;
Kanasaki, Keizo;
Haneda, Masakazu;
Schernthaner, Guntram;
Sharma, Kumar;
Stanton, Robert C.;
Toto, Robert;
Cescutti, Jessica;
Gordat, Maud;
Meinicke, Thomas;
Koitka‐Weber, Audrey;
Thiemann, Sandra;
von Eynatten, Maximilian

Publication type:

Article

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924

By:

Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Fulcher, Greg;
Erondu, Ngozi;
Desai, Mehul;
Shaw, Wayne;
Law, Gordon;
Walton, Marc K.;
Rosenthal, Norm;
de Zeeuw, Dick;
Matthews, David R.

Publication type:

Article

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 749, doi. 10.1111/dom.12864

By:

Pena, Michelle J.;
de Zeeuw, Dick;
Andress, Dennis;
Brennan, John J.;
Correa‐Rotter, Ricardo;
Coll, Blai;
Kohan, Donald E.;
Makino, Hirofumi;
Perkovic, Vlado;
Remuzzi, Giuseppe;
Tobe, Sheldon W.;
Toto, Robert;
Parving, Hans‐Henrik;
Sharma, Shoba;
Corringham, Tom;
Sharma, Kumar;
Heerspink, Hiddo J. L.

Publication type:

Article

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 545, doi. 10.1111/dom.12851

By:

Heerspink, Hiddo J. L.;
Makino, Hirofumi;
Andress, Dennis;
Brennan, John J.;
Correa‐Rotter, Ricardo;
Coll, Blai;
Davis, Justin W.;
Idler, Ken;
Kohan, Donald E.;
Liu, Mohan;
Perkovic, Vlado;
Remuzzi, Giuseppe;
Tobe, Sheldon W.;
Toto, Robert;
Parving, Hans‐Henrik;
de Zeeuw, Dick

Publication type:

Article

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829

By:

Neal, Bruce;
Perkovic, Vlado;
Matthews, David R.;
Mahaffey, Kenneth W.;
Fulcher, Greg;
Meininger, Gary;
Erondu, Ngozi;
Desai, Mehul;
Shaw, Wayne;
Vercruysse, Frank;
Yee, Jacqueline;
Deng, Hsiaowei;
de Zeeuw, Dick

Publication type:

Article

Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.

Published in:

European Journal of Preventive Cardiology, 2016, v. 23, n. 7, p. 758, doi. 10.1177/2047487315598709

By:

Schievink, Bauke;
de Zeeuw, Dick;
Smink, Paul A;
Andress, Dennis;
Brennan, John J;
Coll, Blai;
Correa-Rotter, Ricardo;
Hou, Fan Fan;
Kohan, Donald;
Kitzman, Dalane W;
Makino, Hirofumi;
Parving, Hans-Henrik;
Perkovic, Vlado;
Remuzzi, Giuseppe;
Tobe, Sheldon;
Toto, Robert;
Hoekman, Jarno;
Lambers Heerspink, Hiddo J

Publication type:

Article

Lowering cholesterol in chronic kidney disease: is it safe and effective?

Published in:

European Heart Journal, 2015, v. 36, n. 43, p. 2988, doi. 10.1093/eurheartj/ehv393

By:

Muh Geot Wong;
Wanner, Christoph;
Knight, John;
Perkovic, Vlado

Publication type:

Article

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

Published in:

European Heart Journal, 2013, v. 34, n. 24, p. 1807, doi. 10.1093/eurheartj/eht065

By:

Hou, Wanyin;
Lv, Jicheng;
Perkovic, Vlado;
Yang, Lihong;
Zhao, Na;
Jardine, Meg J.;
Cass, Alan;
Zhang, Hong;
Wang, Haiyan

Publication type:

Article

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.

Published in:

European Heart Journal, 2010, v. 31, n. 23, p. 2888, doi. 10.1093/eurheartj/ehq139

By:

Lambers Heerspink, Hiddo J.;
Ninomiya, Toshiharu;
Perkovic, Vlado;
Woodward, Mark;
Zoungas, Sophia;
Cass, Alan;
Cooper, Mark;
Grobbee, Diederick E.;
Mancia, Giuseppe;
Mogensen, Carl Eric;
Neal, Bruce;
Chalmers, John

Publication type:

Article

Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 5, p. 1098, doi. 10.1002/cpt.2721

By:

Smeijer, J. David;
Koomen, Jeroen V.;
Kohan, Donald E.;
McMurray, John J. V.;
Bakris, George L.;
Correa‐Rotter, Ricardo;
Hou, Fan‐Fan;
Kitzman, Dalane W.;
Makino, Hirofumi;
Mayer, Gert;
Nowicki, Michal;
Perkovic, Vlado;
Rossing, Peter;
Tobe, Sheldon;
Parving, Hans‐Henrik;
de Zeeuw, Dick;
Heerspink, Hiddo J. L.

Publication type:

Article

Individual Atrasentan Exposure is Associated With Long‐term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1631, doi. 10.1002/cpt.2143

By:

Koomen, Jeroen V.;
Stevens, Jasper;
Bakris, George;
Correa‐Rotter, Ricardo;
Hou, Fan Fan;
Kitzman, Dalane W.;
Kohan, Donald E.;
Makino, Hirofumi;
McMurray, John J. V.;
Parving, Hans‐Henrik;
Perkovic, Vlado;
Tobe, Sheldon W.;
Zeeuw, Dick;
Heerspink, Hiddo J. L.

Publication type:

Article

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01619-0

By:

Tye, Sok Cin;
Jongs, Niels;
Coca, Steven G.;
Sundström, Johan;
Arnott, Clare;
Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Vart, Priya;
Heerspink, Hiddo. J. L.

Publication type:

Article

Emily Atkins and Vlado Perkovic, the authors of the article, comment.

Published in:

Australian Prescriber, 2019, v. 42, n. 6, p. 181

By:

Atkins, Emily;
Perkovic, Vlado

Publication type:

Article

Blood pressure: at what level is treatment worthwhile?

Published in:

Australian Prescriber, 2019, v. 42, n. 4, p. 127, doi. 10.18773/austprescr.2019.038

By:

Atkins, Emily R.;
Perkovic, Vlado

Publication type:

Article

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132

By:

Heerspink, Hiddo J L;
Agarwal, Rajiv;
Bakris, George L;
Cherney, David Z I;
Lam, Carolyn S P;
Neuen, Brendon L;
Sarafidis, Pantelis A;
Tuttle, Katherine R;
Wanner, Christoph;
Brinker, Meike D;
Dizayee, Sara;
Kolkhof, Peter;
Schloemer, Patrick;
Vesterinen, Paula;
Perkovic, Vlado;
investigators, for the FIND-CKD

Publication type:

Article

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009

By:

Rossing, Peter;
Baeres, Florian M M;
Bakris, George;
Bosch-Traberg, Heidrun;
Gislum, Mette;
Gough, Stephen C L;
Idorn, Thomas;
Lawson, Jack;
Mahaffey, Kenneth W;
Mann, Johannes F E;
Mersebach, Henriette;
Perkovic, Vlado;
Tuttle, Katherine;
Pratley, Richard

Publication type:

Article

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342

By:

Singh, Ajay K;
McCausland, Finnian R;
Claggett, Brian L;
Wanner, Christoph;
Wiecek, Andrzej;
Atkins, Michael B;
Carroll, Kevin;
Perkovic, Vlado;
McMurray, John J V;
Wittes, Janet;
Snapinn, Steven;
Blackorby, Allison;
Meadowcroft, Amy;
Barker, Tara;
DiMino, Tara;
Mallett, Stephen;
Cobitz, Alexander R;
Solomon, Scott D

Publication type:

Article

Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 6, p. 1448, doi. 10.1093/ndt/gfac289

By:

Mathur, Vandana S;
Bushinsky, David A;
Inker, Lesley;
Klaerner, Gerrit;
Li, Elizabeth;
Parsell, Dawn;
Perkovic, Vlado;
Stasiv, Yuri;
Walker, Michael;
Wesson, Donald E;
Wheeler, David C;
Tangri, Navdeep

Publication type:

Article

ASCEND-ND trial: study design and participant characteristics.

Published in:

Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318

By:

Perkovic, Vlado;
Blackorby, Allison;
Cizman, Borut;
Carroll, Kevin;
Cobitz, Alexander R;
Davies, Rich;
DiMino, Tara L;
Jha, Vivekanand;
Johansen, Kirsten L;
Lopes, Renato D;
Kler, Lata;
Macdougall, Iain C;
McMurray, John J V;
Meadowcroft, Amy M;
Obrador, Gregorio T;
Solomon, Scott;
Taft, Lin;
Wanner, Christoph;
Waikar, Sushrut S;
Wheeler, David C

Publication type:

Article